Work

Safety of First-Line Letrozole Compared with Lapatinib Plus Letrozole in Patients with Postmenopausal Hormone Receptor Positive Metastatic Breast Cancer: EGF30008 Study.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-09-5094

Authors: J. Ro, J. Pippen, X. Pivot, A. Manikhas, L. Fehrenbacher, A. Makris, A. Florance, J. Maltzman, L. O'Rourke, S. Johnson

Institutions: National Cancer Center, Centre Hospitalier Universitaire de Besançon, City Clinical Oncology Center, Kaiser Permanente, Mount Vernon Hospital, Mount Vernon Hospital, GlaxoSmithKline (United States), Royal Marsden NHS Foundation Trust, Institute of Cancer Research

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2331292684

Cites:

Cited by: 4

Related to: 10